https://www.selleckchem.com/pr....oducts/guanosine.htm
We read with interest the Letter to the Editor by Kerschbaumer et al regarding our article on the primary results from the SEAM-PsA trial (1). We appreciated the comments highlighting the methotrexate (MTX) monotherapy results. Since MTX is a drug that has been long used in psoriatic arthritis (PsA) without much data from rigorous and well-controlled clinical trials, we sought to provide reliable data about MTX through SEAM-PsA. This article is protected by copyright. All rights reserved.A large number of reactive oxygen species (ROS)
Like
Comment
Share
